SNOA logo

Sonoma Pharmaceuticals (SNOA) Company Overview

Profile

Full Name:

Sonoma Pharmaceuticals, Inc.

Sector:

Healthcare

Country:

United States

IPO:

January 25, 2007

Indexes:

Not included

Description:

Sonoma Pharmaceuticals is a healthcare company that develops and sells innovative products for skin and wound care. They focus on using advanced technology to create effective treatments for various conditions, including infections and inflammation, aiming to improve patient outcomes and enhance quality of life.

Events Calendar

Earnings

Next earnings date:

Jun 17, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Jun 17, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 30, 2024

Analyst ratings

Recent major analysts updates

Sep 5, 23 Ladenburg Thalmann
Buy
Nov 25, 20 Maxim Group
Buy
Nov 25, 20 Benchmark
Speculative Buy
Mar 6, 18 Maxim Group
Hold
Dec 28, 17 Benchmark
Speculative Buy
Nov 10, 17 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Sonoma Pharmaceuticals?
  • Does Sonoma Pharmaceuticals pay dividends?
  • What sector is Sonoma Pharmaceuticals in?
  • What industry is Sonoma Pharmaceuticals in?
  • What country is Sonoma Pharmaceuticals based in?
  • When did Sonoma Pharmaceuticals go public?
  • Is Sonoma Pharmaceuticals in the S&P 500?
  • Is Sonoma Pharmaceuticals in the NASDAQ 100?
  • Is Sonoma Pharmaceuticals in the Dow Jones?
  • When was Sonoma Pharmaceuticals's last earnings report?
  • When does Sonoma Pharmaceuticals report earnings?
  • Should I buy Sonoma Pharmaceuticals stock now?

What is the ticker symbol for Sonoma Pharmaceuticals?

The ticker symbol for Sonoma Pharmaceuticals is NASDAQ:SNOA

Does Sonoma Pharmaceuticals pay dividends?

No, Sonoma Pharmaceuticals does not pay dividends

What sector is Sonoma Pharmaceuticals in?

Sonoma Pharmaceuticals is in the Healthcare sector

What industry is Sonoma Pharmaceuticals in?

Sonoma Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Sonoma Pharmaceuticals based in?

Sonoma Pharmaceuticals is headquartered in United States

When did Sonoma Pharmaceuticals go public?

Sonoma Pharmaceuticals's initial public offering (IPO) was on January 25, 2007

Is Sonoma Pharmaceuticals in the S&P 500?

No, Sonoma Pharmaceuticals is not included in the S&P 500 index

Is Sonoma Pharmaceuticals in the NASDAQ 100?

No, Sonoma Pharmaceuticals is not included in the NASDAQ 100 index

Is Sonoma Pharmaceuticals in the Dow Jones?

No, Sonoma Pharmaceuticals is not included in the Dow Jones index

When was Sonoma Pharmaceuticals's last earnings report?

Sonoma Pharmaceuticals's most recent earnings report was on Feb 5, 2025

When does Sonoma Pharmaceuticals report earnings?

The next expected earnings date for Sonoma Pharmaceuticals is Jun 17, 2025

Should I buy Sonoma Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions